These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28989013)

  • 1. Development of a Modified-Release Formulation of Lovastatin Targeted to Intestinal Methanogens Implicated in Irritable Bowel Syndrome With Constipation.
    Hubert S; Chadwick A; Wacher V; Coughlin O; Kokai-Kun J; Bristol A
    J Pharm Sci; 2018 Feb; 107(2):662-671. PubMed ID: 28989013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase in
    Ghoshal U; Shukla R; Srivastava D; Ghoshal UC
    Gut Liver; 2016 Nov; 10(6):932-938. PubMed ID: 27458176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath.
    Kim G; Deepinder F; Morales W; Hwang L; Weitsman S; Chang C; Gunsalus R; Pimentel M
    Dig Dis Sci; 2012 Dec; 57(12):3213-8. PubMed ID: 22573345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway.
    Muskal SM; Sliman J; Kokai-Kun J; Pimentel M; Wacher V; Gottlieb K
    F1000Res; 2016; 5():606. PubMed ID: 27347377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders.
    Gottlieb K; Wacher V; Sliman J; Pimentel M
    Aliment Pharmacol Ther; 2016 Jan; 43(2):197-212. PubMed ID: 26559904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of cultured human methanogens to lovastatin.
    Demonfort Nkamga V; Armstrong N; Drancourt M
    Int J Antimicrob Agents; 2017 Feb; 49(2):176-182. PubMed ID: 27955920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet.
    Park HJ; Jung HJ; Ho MJ; Lee DR; Cho HR; Choi YS; Jun J; Son M; Kang MJ
    Eur J Pharm Sci; 2017 May; 102():172-179. PubMed ID: 28279763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
    Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
    Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study.
    Pimentel M; Chatterjee S; Chow EJ; Park S; Kong Y
    Dig Dis Sci; 2006 Aug; 51(8):1297-301. PubMed ID: 16832617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets.
    Vemula SK
    AAPS PharmSciTech; 2015 Dec; 16(6):1465-73. PubMed ID: 26017285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome.
    Kasir R; Zakko S; Zakko P; Adler M; Lee A; Dhingra S; Guttermuth C
    Dig Dis Sci; 2016 Mar; 61(3):846-51. PubMed ID: 26362282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
    Gale JD
    Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].
    Łokieć K; Klupińska G; Walecka-Kapica E; Błońska A
    Pol Merkur Lekarski; 2014 May; 36(215):307-10. PubMed ID: 24964506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methane and Constipation-predominant Irritable Bowel Syndrome: Entwining Pillars of Emerging Neurogastroenterology.
    Bin Waqar SH; Rehan A
    Cureus; 2019 May; 11(5):e4764. PubMed ID: 31363445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of experiment approach for formulating multi-unit colon-targeted drug delivery system: in vitro and in vivo studies.
    Shah N; Sharma OP; Mehta T; Amin A
    Drug Dev Ind Pharm; 2016; 42(5):825-35. PubMed ID: 27019195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
    Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S
    J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin in Aspergillus terreus: fermented rice straw extracts interferes with methane production and gene expression in Methanobrevibacter smithii.
    Faseleh Jahromi M; Liang JB; Ho YW; Mohamad R; Goh YM; Shokryazdan P; Chin J
    Biomed Res Int; 2013; 2013():604721. PubMed ID: 23710454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
    Thomas RH; Luthin DR
    Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.